Intestinal microbiota: Relationships with obesity
DOI:
https://doi.org/10.33448/rsd-v13i10.47009Keywords:
Obesity; Dysbiosis; Gastrointestinal microbiome.Abstract
Objective: To elucidate the relationship between changes in the intestinal microbiota and weight gain, to describe the composition of the intestinal microbiota in obese individuals and the conditions provided by the intestinal microbiota that favor an increase in the number of adipocytes in these individuals. Methods: Descriptive literature review with bibliographic research carried out in the first half of 2023, using the PubMed and Virtual Health Library (VHL) databases. Articles in English, Portuguese and Spanish were selected, which fit the objectives of this review. The selection was based on the Prisma 2009 protocol, going through the steps: inclusion, eligibility, selection and identification of articles and these were dated from the last 5 years. The descriptors used were “obesity”, “dysbiosis” and ''intestinal microbiota''. Results: Changes in the composition of the microbiota after an active and healthy lifestyle are associated with a positive balance between intestinal bacteria: Firmicutes and Bacterioidetes which, in turn, time, showed greater availability of nutrients. Intestinal bacterial diversity is closely linked to more stable individuals, resistant to pathogenic invasions and with no overweight or obesity. Conclusion: The articles studied showed that dysbiosis causes changes in the functioning of the intestinal barrier, generating inflammation, which will contribute to insulin resistance and weight gain. However, more robust studies are needed to continue to reveal the interactions between the intestinal microbiota and obesity.
References
Abenavoli, L; Scarpellini, E; Colica, C; Boccuto, L; Salehi, B; Sharifi-Rad, J et al. (2019). Gut microbiota and obesity: a role for probiotics. Nutrients. 2019. https://www.ncbi.nlm.nih.gov/pmc/articles/pmc6893459/.
Adalsteinsdottir, S A; Magnusdottir, O K; Halldorsson, T I & Birgisdottir, B E. (2018). towards an individualized nutrition treatment: role of the gastrointestinal microbiome in the interplay between diet and obesity. Current Obesity Reports. 2018.
Alcântara, A C F de; Vercoza, E N M & Campos, T A. (2020). Revisão sistemática: o desequilibrio da microbiota intestinal e sua influência na obesidade. Revista Eletrônica da Estácio Recife. 2020. https://reer.emnuvens.com.br/reer/article/view/439.
Amabebe, E; Robert, F O; Agbalalah, T & Orubu, E S F. (2020). Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism. British Journal of Nutrition.
Louzano, S, A R, De Moura, E D M; Lopes da Conceição L; Mendes T, A O & Gouveia Peluzio, M C. (2022). Ceftriaxone causes dysbiosis and changes intestinal structure in adjuvant obesity treatment. Pharmacological Reports: Pr. 2022. https://pubmed.ncbi.nlm.nih.gov/34757518/.
Aragón-ela, J; Solis-Urra, P; Ruiz-Ojed,a F J; Álvarez-Mercado, A I; Olivares-Arancibia, J & Plaza-Diaz, J. (2021). Impact Of Exercise On Gut Microbiota In Obesity. Nutrients. 2021.
Associação Brasileira para o Estudo da Obesidade e Síndrome Metabólica - Abeso, (2016). Diretrizes Brasileiras de obesidade, (4ª Ed.).
Baothman, A O; Zamzami, M A; Taher, I; Abubaker, J; Abu-Farha, M. (sd). The role of gut microbiota in the development of obesity and diabetes. Lipids In Health and Disease. https://www.ncbi.nlm.nih.gov/pmc/articles/pmc4912704/.
Barczyńska, R; Litwin, M; Sliżewska, K; Szalecki, M; Berdowska, A; Bandurska, K et al. (2018). Bacterial microbiota and fatty acids in the faeces of overweight and obese children. Polish Journal of Microbiology. https://www.ncbi.nlm.nih.gov/pmc/articles/pmc7256813/.
Boas V, & Ribeiro F B. (2017). Obesidade e sua possível relação com a microbiota intestinal. Repositoriouniceubbr. https://repositorio.uniceub.br/jspui/handle/235/11720.
Borges, F M; Paula, T O de; Gameiro, J; Silva, V l da & Diniz, C G. (2014). Papel da microbiota na modulação da homeostase dos hospedeiros: correlação entre micobioma intestinal e obesidade. Hu Revista. 2014. https://periodicos.ufjf.br/index.php/hurevista/article/view/2452.
Brusaferro, A; Cozzali, R; Orabona, C; Biscarini, A; Farinelli, E, Cavalli, E et al. (2018). Is it time to use probiotics to prevent or treat obesity? Nutrients.
Cancello, R; Turroni, S; Rampelli, S; Cattaldo, S; Candela, M; Cattani, L et al. (2019). Effect of short-term dietary intervention and probiotic mix supplementation on the gut microbiota of elderly obese women. Nutrients.
Cândido, T L N; Bressan, J & Alfenas, R C G. (sd). dysbiosis and metabolic endotoxemia induced by high-fat diet. Nutr Hosp. https://pesquisa.bvsalud.org/portal/resource/pt/ibc-181486.
Chan, Y K; Estaki, M & Gibson ,D l. (2013). Clinical consequences of diet-induced dysbiosis. annals of nutrition and metabolism. https://www.nestlenutrition-institute.org/docs/default-source/global-dcoument-library/publications/secured/eb9c08c1e21c5addafdc5af97edae491. pdf?sfvrsn=0.
Coelho, O G L, Cândido, F G, & Alfenas, R de C G. (2018). Dietary fat and gut microbiota: mechanisms involved in obesity control. Critical Reviews in Food Science and Nutrition.
Crovesy, L.; Masterson, D.; & Rosado, E L (2020). Perfil da microbiota intestinal de adultos com obesidade: uma revisão sistemática. Eur. J. Clin. Nutr.
Cuevas-Sierra, A, Ramos-Lopez, O, Riezu-Boj, J I, Milagro, F I & Martinez, J A. (2019). Diet, gut microbiota, and obesity: links with host genetics and epigenetics and potential applications. Advances in Nutrition. https://academic.oup.com/advances/article/10/suppl_1/s17/5307226.
Díez-Sainz, E, Milagro, F I, Riezu-Boj, J I, & Lorente-Cebrián, S. (2022). Effects of gut microbiota-derived extracellular vesicles on obesity and diabetes and their potential modulation through diet. Journal of Physiology and Biochemistry. 2022. https://pubmed.ncbi.nlm.nih.gov/34472032/.
Ellulu, M S; Patimah, I.; Khaza'ai, H.; Rahmat, A.; & Abed, Y. (2017). Obesidade e inflamação: o mecanismo de ligação e as complicações. Arco. Med. Sci.
Epaminondas de Souza, E.; Lima, Querino de Farias, K.; Gomes, N I G & Ataide Lima, R P . (2017). Relação entre obesidade e microbiota intestinal: um estudo de revisão.II Congresso Brasileiro de Ciências da Saúde.
Feijó Figueiredo, M C; Silva Araújo, D.; Ferreira do Nascimento, J M; Pereira de Moura, F V; Ramos Silva, T.; Dias Barros, F D et al. (2020). Efeitos dos probióticos sobre a microbiota intestinal e metabolismo de idosos. Research, Society and Development, 9(4).
Frank, J; Gupta, A; Osadchiy, V & Mayer, E A. (2021). Brain–gut–microbiome interactions and intermittent fasting in Obesity. Nutrients.
Fujisaka, S; Watanabe, Y & Tobe, K. (2022). The gut microbiome: a core regulator of metabolism. Journal of Endocrinology. 2022 Dec.
Gagliardi, A; Totino, V; Cacciotti, F; Iebba, V; Neroni, B; Bonfiglio, G et al. (2018). Rebuilding the gut microbiota ecosystem. International journal of environmental Research and Public Health. https://www.ncbi.nlm.nih.gov/pmc/articles/pmc6121872/#b69-ijerph-15-01679.
Gamarra Taborda Flesch, A.; Kirjner Poziomyck, A.; & De Carvalho Damin, D. (2014). O uso terapêutico dos simbióticos. Arquivos Brasileiros de Cirurgiadigestiva, São Paulo, 27(3), 206-209.
Gao, R; Zhu, C; Li, H; Yin, M; Pan, C; Huang, L et al. (2017). Dysbiosis Signatures of gut microbiota along the sequence from healthy, young patients to those with overweight and obesity. Obesity.
Gasmi, A; Mujawdiya, P K; Pivina, L; Doşa, A; Semenova, Y; Benahmed, A G et al. (sd). Relationship between gut microbiota, gut hyperpermeability and obesity. Current Medicinal Chemistry. https://www.eurekaselect.com/article/108391.
Geng, J; Ni, Q; Sun, W; Li, L & Feng, X. (2022). The links between gut microbiota and obesity and obesity related diseases. Biomedicine & Pharmacotherapy.
Gomes, A C; Hoffmann, C & Mota, J F. (2018). The human gut microbiota: metabolism and perspective in obesity. Gut Microbes.
Green, M; Arora, K & Prakash, S. (2020). Microbial medicine: prebiotic and probiotic functional foods to target obesity and metabolic syndrome. International Journal of Molecular Sciences. 2020.
Guirro, M; Costa, A; Gual-Grau, A; Herrero, P; Torrell, H, Canela, N et al. (2019). Effects from diet-induced gut microbiota dysbiosis and obesity can be ameliorated by fecal microbiota transplantation: a multiomics approach. Nerurkar Pv, editor. plos one.
Hypocaloric Mediterranean diet on the gut microbiota composition of italian obese patients. Nutrients. (2020).
Icaza-Chávez, M E. (2013). Microbiota intestinal en la salud y la enfermedad. Revista de Gastroenterología de México https://www.sciencedirect.com/science/article/pii/s0375090613001468.
Islam, M R; Arthur, S; Haynes, J; Butts, M R; Nepal, N & Sundaram ,U. (2022). The role of gut microbiota and metabolites in obesity-associated chronic gastrointestinal disorders. Nutrients. https://www.ncbi.nlm.nih.gov/pmc/articles/pmc8838694/.
Klancic, T, & Reimer ,R A. (2019). Gut microbiota and obesity: impact of antibiotics and prebiotics and potential for musculoskeletal health. Journal of Sport And Health Science.
Lane, M.; Howland, G.; Oeste, M.; Hóquei, M.; Marx, W.; Loughman, A.; et al. (2020). O efeito de dietas ultraprocessadas de muito baixa energia na microbiota intestinal e resultados metabólicos em indivíduos com obesidade: uma revisão sistemática da literatura. Austrália: Obes. Res. Clin. Pratique.
Leonario-Rodriguez M & Saavedra, N. (2022). Microbiota intestinal y modulación del tejido adiposo en la patogénesis de la obesidad. Archivos Latinoamericanos de Nutrición.
Li, P; Chang, X; Chen, X; Wang, C; Shang, Y; Zheng, D, et al. (2022). Early-life antibiotic exposure increases the risk of childhood overweight and obesity in relation to dysbiosis of gut microbiota: a birth cohort study. Annals of Clinical Microbiology And Antimicrobials. https://www.ncbi.nlm.nih.gov/pmc/articles/pmc9635112/.
Liu, B N; Liu, X T; Liang, Z H & Wang, J H. (2021). World journal of gastroenterology gut microbiota in obesity manuscript source: invited manuscript. World J Gastroenterol. 2021. https://www.ncbi.nlm.nih.gov/pmc/articles/pmc8291023/pdf/wjg-27-3837.pdf.
Longo, M.; Zatterale, F.; Naderi, J.; Parrillo, L.; Formisano, P.; Raciti, G A; et al. (2019). Disfunção do tecido adiposo como determinante de complicações metabólicas associadas à obesidade. Int. J. Mol. Sci.
López M. (2017). Eje Prize 2017: hypothalamic ampk: a golden target against obesity? European Journal of Endocrinology.
López-Moreno, A; Suárez, A; Avanzi, C; Monteoliva-Sánchez, M & Aguilera, M. (2020). Probiotic strains and intervention total doses for modulating obesity-related microbiota dysbiosis: a systematic review and meta-analysis. Nutrients.
Machate, D J; Figueiredo, P S; Marcelino, G; Guimarães, R de C A; Hiane, P A, Bogo, D et al. (2020). Fatty acid diets: regulation of gut microbiota composition and obesity and its related metabolic dysbiosis. International Journal of Molecular Sciences.
Magne, F; Gotteland, M; Gauthier, L; Zazueta, A; Pesoa, S; Navarrete ,P et al. (2020). the firmicutes/bacteroidetes ratio: a relevant marker of gut dysbiosis in obese patients? Nutrients. 2020. https://www.ncbi.nlm.nih.gov/pmc/articles/pmc7285218/.
Moraes, M dos S; Oliveira, L P dos S; Furtado, C de C & Gonzalez, F G. (2018). Efeitos funcionais dos probióticos com ênfase na atuação do kefir no tratamento da disbiose intestinal. Unilus Ensino e Pesquisa. Http://Revista.Unilus.Edu.Br/Index.Php/Ruep/Article/View/939.
Moszak, M; Szulińska, M, & Bogdański, P. (2020). You are what you eat-the relationship between diet, microbiota, and metabolic disorders-a review. Nutrients. 2020. https://www.ncbi.nlm.nih.gov/pubmed/32326604.
Nagpal, R; Newman, T M; Wang, S; Jain, S; Lovato, J F & Yadav, H. (2018). Obesity-linked gut microbiome dysbiosis associated with derangements in gut permeability and intestinal cellular homeostasis independent of diet. Journal of Diabetes Research. 2018.
Novelle, M G. (2021). Decoding the role of gut-microbiome in the food addiction paradigm. international journal of environmental research and public health. 2021. Https://www.ncbi.nlm.nih.gov/pmc/articles/pmc8297196/.
Paludo, N. (2019). Desenvolvimento e caracterização de kombucha obtida a partir de chá verde e extrato de erva-mate : processo artesanal e escala laboratorial. Lumeufrgsbr. 2017. https://lume.ufrgs.br/handle/10183/174899.
Pantoja, C L; Cunha Costa, A C; Lavignede Sousa Costa, P; Almeida Hingel Andrade, M.; Vieira Silva, V.; Santos Oliveira Brito, A P et al. (2019). Diagnóstico e tratamentoda disbiose: revisão sistemática. Revista Eletrônica Acervo Saúde, Belém-Pará, 32, 1-7.
Pisanu, S; Palmas, V; Madau ,V; Casula, E; Deledda, A; Cusano, R et al. (2020). Impact of a moderately hypocaloric mediterranean diet on the gut microbiota composition of italian obese patients. Nutrients. 2020.
Rodriguez, J; Olivares, M & Delzenne, N M. (2020). Implication of the gut microbiota in metabolic inflammation associated with nutritional disorders and obesity. Molecular Nutrition & Food Research.
Si, X; Shang, W; Zhou, Z; Strappe, P; Wang, B; Bird, A et al. (2018). Gut microbiome-induced shift of acetate to butyrate positively manages dysbiosis in high fat diet. Molecular Nutrition & Food Research.
Silva Gomes, V T; Gomes, R N S; Gomes, M S; Viana, L V M; da Conceição, F R; Soares, E L et al. (2017). Benefícios da biomassa de banana verde á saúde humana. Revista Univap. 2017.
Stephens, R W; Arhire, L & Covasa, M. (2018). Gut microbiota: from microorganisms to metabolic organ influencing obesity. Obesity.
Strindmo, I S M. (2016). Prevalence of dysbiosis and microbiotic effect of the low fodmap diet in coeliac disease patients with ibs-like symptoms. bora.uib.no. 2016. Https://Hdl.Handle.Net/1956/13024.
Tang, Q; Wang, C; Jin, G; Li, Y; Hou, H; Wang, X, et al. (2022). Early life dietary emulsifier exposure predisposes the offspring to obesity through gut microbiota-fxr axis. Food Research International. https://www.sciencedirect.com/science/article/abs/pii/s0963996922009796.
The role of diet and intestinal microbiota (2019). In the development of metabolic syndrome. The Journal of Nutritional Biochemistry. Https://Www.Sciencedirect.Com/Science/Article/Pii/S0955286318309318.
Tokarek, J; Gadzinowska, J; Młynarska, E; Franczyk, B & Rysz, J. (2021). What is the role of gut microbiota in obesity prevalence? a few words about gut microbiota and its association with obesity and related diseases. Microorganisms. 2021.
Turner, A; Veysey, M; Keely, S; Scarlett, C; Lucock, M & Beckett, E. (2018). Interactions Between Bitter Taste, Diet And Dysbiosis: Consequences For Appetite And Obesity. Nutrients. 2018.
Vallianou, N; Dalamaga, M; Stratigou, T; Karampela, I & Tsigalou, C. (2021). Do antibiotics cause obesity through long-term alterations in the gut microbiome? A review of current evidence. Current Obesity Reports.
Vallianou, N; Stratigou, T; Christodoulatos, G S & Dalamaga, M. (2019). Understanding the role of the gut microbiome and microbial metabolites in obesity and obesity-associated metabolic disorders: Current evidence and perspectives. Current Obesity Reports.
Van Son ,J; Koekkoek, L L; La Fleur, S E; Serlie, M J & Nieuwdorp, M. (2021). The role of the gut microbiota in the gut–brain axis in obesity: mechanisms and future implications. International Journal of Molecular Sciences. 2021.
Vieira, C. R. (2016). Efeito da abordagem nutricional e o uso de probióticos no tratamento da disbiose. 28f. Monografia (Especialização em Nutrição Clínica Funcional) -Universidade Cruzeiro do Sul, São Paulo.
Wanderley, E N & Ferreira, V A. (2010). Obesidade: uma perspectiva plural. Ciência & Saúde Coletiva. 2010. Https://Www.Scielosp.Org/Article/Csc/2010.V15n1/185-194/Pt/.
Wei, Y X.; Zheng, K Y & Wang, Y G. (2021). Gut microbiota-derived metabolites as key mucosal barrier modulators in obesity. World Journal of Gastroenterology. 2021.
Weiss, G A, & Hennet, T. (2017). Mechanisms and consequences of intestinal dysbiosis. cellular and molecular life sciences : CMLS. 2017. Https://Www.Ncbi.Nlm.Nih.Gov/Pubmed/28352996.
World Health Organization -Who (2021). Obesity. Who. Who; 2021. Https://Www.Who.Int/News-Room/Facts-In-Pictures/Detail/6-Facts-On-Obesity.
Zhuang, T; Li, W.; Yang, L.; Wang, Z; Ding L. & Zhou, M. (2021). Gut microbiota: novel therapeutic target of ginsenosides for the treatment of obesity and its complications. Frontiers In Pharmacology.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Luana Facundo R. Borges; Darlla Célia K. M. Modesto; Luciana Morelli Caldeira
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
